Intuitive Surgical Inc. (ISRG) Earns Buy Rating from JPMorgan Chase & Co.
Intuitive Surgical Inc. (NASDAQ:ISRG)‘s stock had its “buy” rating reiterated by equities research analysts at JPMorgan Chase & Co. in a research report issued on Tuesday.
The analysts wrote, “Over the weekend, we attended the second annual Global Symposium on Robotic Assisted and Minimally Invasive Hernia Repair, which was a gathering of >250 general surgeons in New York. The meeting was positive for Intuitive Surgical (ISRG), as interest in robotic hernia repair has increased since last year, with a number of presentations highlighting both clinical and cost data, while there was broader acknowledgement that robotics is the future for hernia repair (including by ISRG’s Chief Medical Officer, who not surprisingly, spoke positively about potential future adoption, with potential for it to eventually reach 40-50% penetration). Following the conference, along with our recent physician survey (see note here), we are increasingly confident that hernia is a legitimate opportunity for ISRG, and should continue to be a primary driver of sustainable procedure growth over the near to intermediate term.””
Several other research firms have also recently commented on ISRG. Northland Securities cut Intuitive Surgical from a “market perform” rating to an “under perform” rating and set a $600.00 price objective on the stock. in a research report on Thursday, July 21st. BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Tuesday. Zacks Investment Research raised Intuitive Surgical from a “sell” rating to a “hold” rating and set a $772.00 price objective on the stock in a research report on Friday, July 22nd. Raymond James Financial Inc. began coverage on Intuitive Surgical in a research report on Friday, August 26th. They set an “outperform” rating on the stock. Finally, Leerink Swann reaffirmed an “outperform” rating and set a $780.00 price objective on shares of Intuitive Surgical in a research report on Monday. One analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. Intuitive Surgical has a consensus rating of “Buy” and a consensus price target of $701.42.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/intuitive-surgical-inc-isrg-earns-buy-rating-from-jpmorgan-chase-co.html
Intuitive Surgical (NASDAQ:ISRG) traded up 0.77% on Tuesday, hitting $698.87. 281,016 shares of the company traded hands. Intuitive Surgical has a 1-year low of $447.00 and a 1-year high of $720.01. The firm has a market capitalization of $26.90 billion, a PE ratio of 39.66 and a beta of 0.73. The firm’s 50 day moving average price is $688.34 and its 200 day moving average price is $647.09.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, July 19th. The company reported $5.62 EPS for the quarter, beating the consensus estimate of $4.97 by $0.65. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. The company had revenue of $670 million for the quarter, compared to analysts’ expectations of $640.69 million. During the same period last year, the firm posted $4.57 earnings per share. Equities research analysts predict that Intuitive Surgical will post $21.30 EPS for the current fiscal year.
In other news, CEO Gary S. Guthart sold 13,400 shares of Intuitive Surgical stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $698.00, for a total transaction of $9,353,200.00. Following the transaction, the chief executive officer now directly owns 78,780 shares of the company’s stock, valued at approximately $54,988,440. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Curet Myriam sold 4,250 shares of Intuitive Surgical stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $684.39, for a total value of $2,908,657.50. Following the transaction, the senior vice president now directly owns 3,133 shares in the company, valued at $2,144,193.87. The disclosure for this sale can be found here. Insiders own 3.10% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Global X Management Co. LLC bought a new position in Intuitive Surgical during the second quarter worth $118,000. Acrospire Investment Management LLC bought a new position in Intuitive Surgical during the first quarter worth $120,000. Bartlett & Co. LLC boosted its position in Intuitive Surgical by 7.3% in the second quarter. Bartlett & Co. LLC now owns 220 shares of the company’s stock worth $146,000 after buying an additional 15 shares during the last quarter. IFP Advisors Inc boosted its position in Intuitive Surgical by 3.3% in the first quarter. IFP Advisors Inc now owns 284 shares of the company’s stock worth $171,000 after buying an additional 9 shares during the last quarter. Finally, Glenmede Trust Co. NA boosted its position in Intuitive Surgical by 3.0% in the second quarter. Glenmede Trust Co. NA now owns 275 shares of the company’s stock worth $181,000 after buying an additional 8 shares during the last quarter. 92.28% of the stock is currently owned by hedge funds and other institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.